OCGN vs. NVAX
OCGN (Ocugen, Inc.) and NVAX (Novavax, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 10 years, OCGN returned -36.03%/yr vs -22.44%/yr for NVAX. At a 0.25 correlation, their price movements are largely independent.
Performance
OCGN vs. NVAX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, OCGN achieves a 1.48% return, which is significantly lower than NVAX's 51.64% return. Over the past 10 years, OCGN has underperformed NVAX with an annualized return of -36.03%, while NVAX has yielded a comparatively higher -22.44% annualized return.
OCGN
- 1D
- 5.38%
- 1M
- -8.05%
- YTD
- 1.48%
- 6M
- 10.48%
- 1Y
- 54.42%
- 3Y*
- 42.80%
- 5Y*
- -30.94%
- 10Y*
- -36.03%
NVAX
- 1D
- -0.10%
- 1M
- 25.80%
- YTD
- 51.64%
- 6M
- 48.54%
- 1Y
- 42.52%
- 3Y*
- 9.09%
- 5Y*
- -43.88%
- 10Y*
- -22.44%
OCGN vs. NVAX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
OCGN Ocugen, Inc. | 1.48% | 67.70% | 40.00% | -55.77% | -71.43% | 148.63% | 251.92% | -90.20% | -95.69% | 22.75% |
NVAX Novavax, Inc. | 51.64% | -16.42% | 67.50% | -53.31% | -92.81% | 28.30% | 2,701.76% | -89.18% | 48.39% | -1.59% |
Correlation
The correlation between OCGN and NVAX is 0.38, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.38 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.30 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.40 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.26 |
Correlation (All Time) Calculated using the full available price history since Dec 4, 2014 | 0.25 |
The correlation between OCGN and NVAX shifts across timeframes, from 0.25 (all time) to 0.40 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
OCGN:
$438.98M
NVAX:
$1.66B
OCGN:
-$0.23
NVAX:
-$0.52
OCGN:
94.26
NVAX:
2.89
OCGN:
$4.47M
NVAX:
$596.34M
OCGN:
$2.93M
NVAX:
$504.72M
OCGN:
-$64.77M
NVAX:
-$57.01M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
OCGN vs. NVAX — Risk / Return Rank
OCGN
NVAX
OCGN vs. NVAX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Ocugen, Inc. (OCGN) and Novavax, Inc. (NVAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| OCGN | NVAX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.04 | ||
| Sortino ratioReturn per unit of downside risk | +0.05 | ||
| Omega ratioGain probability vs. loss probability | 1.18 | 1.16 | +0.02 |
| Calmar ratioReturn relative to maximum drawdown | 1.15 | 1.19 | -0.04 |
| Martin ratioReturn relative to average drawdown | 2.38 | 2.32 | +0.07 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| OCGN | NVAX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.67 | 0.63 | +0.04 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.34 | -0.42 | +0.08 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.22 | -0.19 | -0.02 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.27 | -0.07 | -0.20 |
Drawdowns
OCGN vs. NVAX - Drawdown Comparison
The maximum OCGN drawdown since its inception was -99.97%, roughly equal to the maximum NVAX drawdown of -98.82%. Use the drawdown chart below to compare losses from any high point for OCGN and NVAX.
Loading charts...
Drawdown Indicators
| OCGN | NVAX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.97% | -98.82% | -1.15% |
Max Drawdown (1Y)Largest decline over 1 year | -47.58% | -35.94% | -11.64% |
Max Drawdown (3Y)Largest decline over 3 years | -73.92% | -74.11% | +0.19% |
Max Drawdown (5Y)Largest decline over 5 years | -97.71% | -98.61% | +0.90% |
Max Drawdown (10Y)Largest decline over 10 years | -99.92% | -98.82% | -1.10% |
Current DrawdownCurrent decline from peak | -99.81% | -96.81% | -3.00% |
Average DrawdownAverage peak-to-trough decline | -89.56% | -70.71% | -18.85% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 22.90% | 18.39% | +4.51% |
Volatility
OCGN vs. NVAX - Volatility Comparison
The current volatility for Ocugen, Inc. (OCGN) is 12.92%, while Novavax, Inc. (NVAX) has a volatility of 26.82%. This indicates that OCGN experiences smaller price fluctuations and is considered to be less risky than NVAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| OCGN | NVAX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.92% | 26.82% | -13.90% |
Volatility (6M)Calculated over the trailing 6-month period | 63.43% | 50.66% | +12.77% |
Volatility (1Y)Calculated over the trailing 1-year period | 81.71% | 68.10% | +13.61% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 91.76% | 106.03% | -14.27% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 166.47% | 115.45% | +51.02% |
Dividends
OCGN vs. NVAX - Dividend Comparison
Neither OCGN nor NVAX has paid dividends to shareholders.
Financials
OCGN vs. NVAX - Financials Comparison
This section allows you to compare key financial metrics between Ocugen, Inc. and Novavax, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
OCGN and NVAX have a correlation of 0.38, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NVAX has higher volatility (26.82%) compared to OCGN (12.92%). In terms of maximum drawdown, OCGN dropped -99.97% vs NVAX's -98.82%.
OCGN currently has the higher Sharpe Ratio (0.67 vs 0.63), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for OCGN and NVAX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer